Solutions
Digital Cognitive Assessment
Endpoint Data Quality (Rater Services)
Remote Assessment
Scientific Consulting
Healthcare Cognitive Screening
Research and Academic Collaborations
Therapeutic Expertise
Alzheimer’s Disease and Dementia
Preclinical Alzheimer’s Disease
Pediatrics & Rare Disease
Parkinson’s Disease
Multiple Sclerosis
Schizophrenia
Oncology
Safety
Resources
Fact Sheets
Webinars
Posters
Publications
Blog
Company
About Cogstate
Leadership Teams
Clinical & Scientific Network (LEADs)
Company News
Careers & Life at Cogstate
CTAD 2023
Investor Centre
Corporate Governance
Board of Directors
ASX Announcements & Share Price
Financial Reports
Investor Presentations
Financial Calendar
Shareholder Information
Contact Us
Support
Solutions
Digital Cognitive Assessment
Endpoint Data Quality (Rater Services)
Remote Assessment
Scientific Consulting
Healthcare Cognitive Screening
Research and Academic Collaborations
Therapeutic Expertise
Alzheimer’s Disease and Dementia
Preclinical Alzheimer’s Disease
Pediatrics & Rare Disease
Parkinson’s Disease
Multiple Sclerosis
Schizophrenia
Oncology
Safety
Resources
Fact Sheets
Webinars
Posters
Publications
Blog
Company
About Cogstate
Leadership Teams
Clinical & Scientific Network (LEADs)
Company News
Careers & Life at Cogstate
CTAD 2023
Investor Centre
Corporate Governance
Board of Directors
ASX Announcements & Share Price
Financial Reports
Investor Presentations
Financial Calendar
Shareholder Information
Contact Us
Support
Latest News
Find updates from Cogstate, leaders in the measurement of cognition.
Search
Show All
June 4, 2018
Cogstate announces European approval for Healthcare offering
October 11, 2017
Cogstate Announces First U.S. Deployment of the Cognigram™ System at the University of Notre Dame
July 27, 2017
Cogstate receives positive FDA notification regarding medical device regulatory submission
